An efficacy trial of the malaria vaccine SPf66 in Gambian infants - Second year of follow-up

K. A. Bojang, S. K. Obaro, U. D'Alessandro, S. Bennett, P. Langerock, G. A.T. Targett, B. M. Greenwood

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

In 1994, 630 Gambian infants were immunized with three doses of the synthetic polypeptide malaria vaccine SPf66 or with a control vaccine. No significant protection against first or total attacks of malaria was observed among the children who received SPf66. However, the period of follow-up was short. Thus, 532 children were followed for a second malaria transmission season during which 291 episodes of malaria were detected. Protective efficacies of SPf66 against first attacks of malaria and against all attacks of malaria were 8% [95% CI - 20%, 30%] and 2% [95% CI - 26% 24%] respectively. SPf66 did not provide any significant degree of protection to Gambian infants during a second year of follow-up.

Original languageEnglish (US)
Pages (from-to)62-67
Number of pages6
JournalVaccine
Volume16
Issue number1
DOIs
StatePublished - Jan 1 1998

Fingerprint

Malaria Vaccines
malaria
Malaria
polypeptides
Vaccines
malaria vaccines
vaccines
Peptides
dosage

Keywords

  • Malaria
  • Malaria vaccine
  • Plasmodium falciparum
  • Spf66

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Bojang, K. A., Obaro, S. K., D'Alessandro, U., Bennett, S., Langerock, P., Targett, G. A. T., & Greenwood, B. M. (1998). An efficacy trial of the malaria vaccine SPf66 in Gambian infants - Second year of follow-up. Vaccine, 16(1), 62-67. https://doi.org/10.1016/S0264-410X(97)00159-X

An efficacy trial of the malaria vaccine SPf66 in Gambian infants - Second year of follow-up. / Bojang, K. A.; Obaro, S. K.; D'Alessandro, U.; Bennett, S.; Langerock, P.; Targett, G. A.T.; Greenwood, B. M.

In: Vaccine, Vol. 16, No. 1, 01.01.1998, p. 62-67.

Research output: Contribution to journalArticle

Bojang, KA, Obaro, SK, D'Alessandro, U, Bennett, S, Langerock, P, Targett, GAT & Greenwood, BM 1998, 'An efficacy trial of the malaria vaccine SPf66 in Gambian infants - Second year of follow-up', Vaccine, vol. 16, no. 1, pp. 62-67. https://doi.org/10.1016/S0264-410X(97)00159-X
Bojang, K. A. ; Obaro, S. K. ; D'Alessandro, U. ; Bennett, S. ; Langerock, P. ; Targett, G. A.T. ; Greenwood, B. M. / An efficacy trial of the malaria vaccine SPf66 in Gambian infants - Second year of follow-up. In: Vaccine. 1998 ; Vol. 16, No. 1. pp. 62-67.
@article{77c753e5a8f340c4baeecb1f8e9a579f,
title = "An efficacy trial of the malaria vaccine SPf66 in Gambian infants - Second year of follow-up",
abstract = "In 1994, 630 Gambian infants were immunized with three doses of the synthetic polypeptide malaria vaccine SPf66 or with a control vaccine. No significant protection against first or total attacks of malaria was observed among the children who received SPf66. However, the period of follow-up was short. Thus, 532 children were followed for a second malaria transmission season during which 291 episodes of malaria were detected. Protective efficacies of SPf66 against first attacks of malaria and against all attacks of malaria were 8{\%} [95{\%} CI - 20{\%}, 30{\%}] and 2{\%} [95{\%} CI - 26{\%} 24{\%}] respectively. SPf66 did not provide any significant degree of protection to Gambian infants during a second year of follow-up.",
keywords = "Malaria, Malaria vaccine, Plasmodium falciparum, Spf66",
author = "Bojang, {K. A.} and Obaro, {S. K.} and U. D'Alessandro and S. Bennett and P. Langerock and Targett, {G. A.T.} and Greenwood, {B. M.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0264-410X(97)00159-X",
language = "English (US)",
volume = "16",
pages = "62--67",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - An efficacy trial of the malaria vaccine SPf66 in Gambian infants - Second year of follow-up

AU - Bojang, K. A.

AU - Obaro, S. K.

AU - D'Alessandro, U.

AU - Bennett, S.

AU - Langerock, P.

AU - Targett, G. A.T.

AU - Greenwood, B. M.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - In 1994, 630 Gambian infants were immunized with three doses of the synthetic polypeptide malaria vaccine SPf66 or with a control vaccine. No significant protection against first or total attacks of malaria was observed among the children who received SPf66. However, the period of follow-up was short. Thus, 532 children were followed for a second malaria transmission season during which 291 episodes of malaria were detected. Protective efficacies of SPf66 against first attacks of malaria and against all attacks of malaria were 8% [95% CI - 20%, 30%] and 2% [95% CI - 26% 24%] respectively. SPf66 did not provide any significant degree of protection to Gambian infants during a second year of follow-up.

AB - In 1994, 630 Gambian infants were immunized with three doses of the synthetic polypeptide malaria vaccine SPf66 or with a control vaccine. No significant protection against first or total attacks of malaria was observed among the children who received SPf66. However, the period of follow-up was short. Thus, 532 children were followed for a second malaria transmission season during which 291 episodes of malaria were detected. Protective efficacies of SPf66 against first attacks of malaria and against all attacks of malaria were 8% [95% CI - 20%, 30%] and 2% [95% CI - 26% 24%] respectively. SPf66 did not provide any significant degree of protection to Gambian infants during a second year of follow-up.

KW - Malaria

KW - Malaria vaccine

KW - Plasmodium falciparum

KW - Spf66

UR - http://www.scopus.com/inward/record.url?scp=0031986509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031986509&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(97)00159-X

DO - 10.1016/S0264-410X(97)00159-X

M3 - Article

C2 - 9607010

AN - SCOPUS:0031986509

VL - 16

SP - 62

EP - 67

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 1

ER -